Clovis Oncology Inc (NASDAQ:CLVS)

3.22
Delayed Data
As of Nov 26
 -0.12 / -3.59%
Today’s Change
3.04
Today|||52-Week Range
11.10
-32.92%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 5.50, with a high estimate of 8.00 and a low estimate of 4.75. The median estimate represents a +70.81% increase from the last price of 3.22.

Analyst Recommendations

The current consensus among 5 polled investment analysts is to Hold stock in Clovis Oncology Inc. This rating has held steady since October, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.53
Sales
$39.6M
Reporting Date
Feb 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.64%
 
 
 
 
 
 
Growthannually 47.40%
 
 
 
 
 
 

Sales

Growthquarterly 4.53%
 
 
 
 
 
 
Growthannually -7.45%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.